Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 539872 | NSE Symbol : BAJAJHCARE | ISIN : INE411U01027 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
10-Apr-2025	10-Apr-2025	Change in Other Executives	Outcome of the Board Meeting held on April 10, 2025
05-Feb-2025	11-Feb-2025	Quarterly Results	Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/02/2025 inter alia to consider and approve Un-audited Financial Results of the Company for the Quarter and Nine months ended 31st December 2024 Outcome of the Board Meeting (As per BSE Announcement Dated on 11/02/2025)
11-Nov-2024	14-Nov-2024	Quarterly Results	Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve unaudited financial results for the quarter ended 30th September 2024. Board Meeting outcome (As Per Bse Announcement Dated on 14.11.2024)
16-Sep-2024	19-Sep-2024	Preferential Issue	Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/09/2024 inter alia to consider and approve Allotment of Equity shares and Warrants Outcome of the Board Meeting held to allot equity shares and warrants on preferential basis (As Per BSE Announcement Dated on 19.09.2024)
08-Aug-2024	14-Aug-2024	Quarterly Results	Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2024 inter alia to consider and approve Unaudited financial results for June 2024 and ESOP Board Meeting outcome for unaudited financial results for the quarter ended 30th June, 2024 (As per BSE Announcement dated on 14/08/2024)
05-Jul-2024	10-Jul-2024	Preferential Issue	Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/07/2024 inter alia to consider and approve 1. Proposed fund raising 2. Increase in Authorised share capital of the Company 3. Alteration in the Articles of Association of the Compay 4. Any other business As mentioned in the outcome of the Board Meeting (As per BSE Announcement Dated on 10/07/2024) Revised outcome of Board Meeting held on 10th July, 2024 (As per BSE Announcement Dated on 15/07/2024)
16-May-2024	24-May-2024	Accounts	Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 inter alia to consider and approve 1. Audited Financial Results for the quarter and year ended March 31 2024. 2. Recommend final dividend on equity shares if any for the financial year ended March 31 2024. Outcome of Board Meeting held on 24th May, 2024 (As Per BSE Announcement dated on 24.05.2024)
06-May-2024	06-May-2024	Change in Other Executives	Appointment of Chief Financial Officer of the Company w.e.f. 6th May, 2024 as approved by the Board of Directors at its meeting held on 6th May, 2024 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('Listing Regulations') this is to inform you that the Board of Directors of our Company at its meeting held today i.e. 6th May, 2024, has considered and approved the following: ? Appointment of Mr. Dayashankar Patel as the Chief Financial Officer and Key Managerial Personnel (KMP) of the Company, with effect from 6th May, 2024 as recommended by the Nomination and Remuneration Committee and based on the approval of the Audit Committee of the Company; ? Appointment of M/s. V J Shah & Co., Chartered Accountants, as Internal Auditor of the Company for the FY 2024-25; ? Appointment of V. J. Talati & Co., Cost Accountants, as Cost Auditor of the Company for the FY 2024-25; and ? Appointment of Mr. Haresh Sanghvi, Practicing Company Secretary, as Secretarial Auditor of the Company for the FY 2024-25 Read less.. Board Meeting outcome for: Appointment of CFO Appointment of Secretarial Auditor Appointment of Cost Auditor Appointment of Internal Auditor
03-Feb-2024	09-Feb-2024	Quarterly Results	Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2024 inter alia to consider and approve Pursuant to Regulation 29 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday 9th February 2024 inter alia to: ? Consider and approve unaudited Financial Results for the quarter and nine months ended 31st December 2023 along with the Limited Review Report thereon; and ? Any other matter with the permission of the Chair. Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, ('Listing Regulations') this is to inform you that the Board of Directors of our Company at its meeting held today i.e. 9th February, 2024, has considered and approved the following: ?? Unaudited Standalone Financial Results of the Company for the quarter and nine months ended on 31st December, 2023 along with the Limited Review Report thereon; (enclosed); ?? Resignation of Mr. Rupesh Nikam (DIN: 07007815) from the position of Chief Financial Officer (CFO), Whole Time Director (WTD) and Key Managerial Personnel (KMP) of the Company; and ?? Appointment of Ms. Apurva Bandivadekar as Company Secretary and Compliance Officer, Key Managerial Personnel of the Company pursuant to Section 203 of the Companies Act, 2013, Regulation 6 of Listing Regulations Unaudited results for the quarter ended 31st December, 2023 Resignation of Mr. Rupesh Nikam from the position of CFO and WTD of the Company Appointment of Ms. Apurva Bandivadekar as Company Secretary and Compliance Officer of the Company (As Per BSE Announcement Dated on 09/02/2024)
03-Nov-2023	09-Nov-2023	Quarterly Results	Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/11/2023 inter alia to consider and approve Pursuant to Regulation 29 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Thursday 9th November 2023 inter alia to: -Consider and approve unaudited Financial Result for the quarter/half year ended 30th September 2023. -Any other matter with the permission of the Chair. Unaudited Financial Result for the Quarter/Half year ended 30th September 2023 Outcome of Board Meeting Outcome of Board Meeting - Appointment of Chief Technical Officer. (As Per BSE Announcement dated on 09.11.2023)
07-Aug-2023	14-Aug-2023	Quarterly Results	Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2023 inter alia to consider and approve unaudited financial result for the quarter ended 30th June 2023 and any other matter with the permission of the Chair. Outcome of Board Meeting dated 14th August, 2023. Financial result for the quarter ended 30th June, 2023 (As Per BSE Announcement Dated on 14.08.2023)
28-Jun-2023	28-Jun-2023	Change in Auditors	Appointment of Statutory Auditor Intimation under Regulation 30 of SEBI(LODR) Regulations, 2015 for Outcome of Board Meeting for sale /disposal of Undertaking/Unit(s).
14-Jun-2023	14-Jun-2023	Change in Directors	This is to inform you that, the Board of Directors of the Company at their meeting held today i.e 14th June 2023, has approved the appointment of Mr. Sandeep Shah (DIN: 06402659) as a Non- Executive Independent Director (additional director) on the Board of Director of the Company.
24-May-2023	30-May-2023	Accounts	Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve Pursuant to Regulation 29 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday 30th May 2023 inter alia to: -Consider and approve Audited Financial Result for the quarter and year ended March 31 2023. -Recommend final dividend on equity shares if any for the financial year ended March 31 2023. -Any other matter with the permission of the Chair. You are requested to take the same on record. Recommendation of Final Dividend Outcome of Board Meeting held on 30th May, 2023 & Submission of financial result and recommendation of Final Dividend (As Per BSE Announcement Dated on 30.05.2023)
06-Feb-2023	13-Feb-2023	Quarterly Results	Bajaj Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2023 inter alia to consider and approve Pursuant to Regulation 29 of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation 2015 this is to inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Monday 13th February 2023 inter alia to: Consider and approve unaudited financial result for the quarter and nine months ended 31st December 2022. Any other matter with the permission of the Chair. You are requested to take the same on record. Outcome of Board Meeting & submission of Unaudited Financial Results for the quarter and nine months ended December 31, 2022 (As Per BSE Announcement dated on 13.02.2023)

1 2

LOGIN HERE

Bajaj Healthcare Ltd

Board Meeting